Brazil's Hot New Drug Market Offers Challenges To Would-Be Entrants
This article was originally published in PharmAsia News
Executive Summary
Brazil may be the new emerging-market darling of the pharmaceutical industry, but it failed to reach recently forecast growth levels because it offers a government system hard to crack.